• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Focal Biosciences

Monday, June 03, 2024
Platform for Therapeutics
Company Presentation Theater 3
Focal Biosciences is a spin-off from ETH Zurich developing a high-throughput drug discovery platform to reverse fibrotic diseases by targeting chromatin remodeling with small molecules. Our approach in IPF is focused on reprogramming lung myofibroblasts within tissue-mimicking disease models back to a normal fibroblast state, enabled by machine learning-derived chromatin fingerprints from single-cell imaging data.
Focal Biosciences
Company Website: https://focalbiosciences.com/
Lead Product in Development: Drug discovery platform for IPF/fibrosis

Company HQ City

Monterey

Company HQ State

California

Company HQ Country

United States

CEO/Top Company Official

Dr. Jan Adams

Development Phase of Primary Product

Discovery
Primary Speaker
Glenn Croston, PhD
Chief Operations Officer
Focal Biosciences
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS